title: Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
authors.affiliation: Department of Hematology, Faculty of Medicine, Ankara University, Ankara, Turkey.
authors.forename: Meral
authors.initials: M
authors.lastname: Beksac
authors.forename: Rauf
authors.initials: R
authors.lastname: Haznedar
authors.forename: Tulin
authors.initials: T
authors.lastname: Firatli-Tuglular
authors.forename: Hakan
authors.initials: H
authors.lastname: Ozdogu
authors.forename: Ismet
authors.initials: I
authors.lastname: Aydogdu
authors.forename: Nahide
authors.initials: N
authors.lastname: Konuk
authors.forename: Gulsan
authors.initials: G
authors.lastname: Sucak
authors.forename: Işik
authors.initials: I
authors.lastname: Kaygusuz
authors.forename: Sema
authors.initials: S
authors.lastname: Karakus
authors.forename: Emin
authors.initials: E
authors.lastname: Kaya
authors.forename: Ridvan
authors.initials: R
authors.lastname: Ali
authors.forename: Zafer
authors.initials: Z
authors.lastname: Gulbas
authors.forename: Gulsum
authors.initials: G
authors.lastname: Ozet
authors.forename: Hakan
authors.initials: H
authors.lastname: Goker
authors.forename: Levent
authors.initials: L
authors.lastname: Undar